ArticleWorld journal of microbiology & biotechnology2026
High-throughput antimicrobial efficacy tests on a 384PillarPlate.
Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Preservatives, including antimicrobial compounds, are routinely added to home and personal care products such as dishwashing detergents to prevent microbial contamination during repeated consumer use. Traditional antimicrobial efficacy testing (T-AET) relies on colony counting methods, where microbial cocktails are inoculated into preservative-containing products and plated on agar to measure microbial survival. While considered a gold standard, T-AET is time-consuming, labor-intensive, costly, and prone to variability and error due to manual handling. To address these limitations, we developed a high-throughput, miniature, ATP-based, on-chip AET (O-AET) using a 384PillarPlate platform. Pseudomonas aeruginosa, Enterobacter cloacae, and Staphylococcus aureus were encapsulated in 3% agarose and exposed to test compounds and detergent formulations. ATP levels in viable microbes were quantified using the BacTiter-Glo™ luminescence assay to generate dose-response curves, IC
Indexed as
Identifiers
41758469What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.